We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PLPL market cap is 15.21k. The company's latest EPS is USD -0.1952 and P/E is 0.00.
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | 0 | 0 | -130k | -18k | -706k |
Net Income | -102k | -83k | -69k | 12.77M | -19.8M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 7.26M | 7.26M | 7.26M | 0 | 0 |
Total Liabilities | 26.14M | 26.24M | 25.16M | 421k | 443k |
Total Equity | -18.88M | -18.98M | -17.9M | -421k | -443k |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | N/A | -130k | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | 130k | N/A | N/A |
Market Cap | 15.21k |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 101.42M |
Average Volume (1 week) | 9.16M |
Average Volume (1 Month) | 38.01M |
52 Week Change | 50.00% |
52 Week High | 0.0007 |
52 Week Low | 0.0001 |
Spread (Intraday) | 0 (0%) |
Company Name | Plandai Biotechnology Inc (PK) |
Address |
416 w san ysidro blvd las vegas, nevada 89118 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions